Genetics
Genetics is the study of inheritance. Genetic testing examines a person’s DNA for variations that can confirm or rule out a suspected genetic disease such as CMT. More in the glossary
-

·
On Deck: CMT Genes That Haven’t Been Rated Yet
A new report links AKAP6 to an axonal neuropathy in one family. Here’s why it isn’t in the Open CMT Gene Table yet, what the new candidate list holds, and how many CMT genes there might be.
-

·
What Happened to CMT2A1? KIF1B and the Disputed Rating
In October 2026 ClinGen’s Charcot-Marie-Tooth expert panel rated the KIF1B–CMT2A1 link “Disputed.” Here’s how that label arose, what the panel found, and how to interpret older references to the gene and disease variant.
-

·
CMT and Nutrition: What the Evidence Says
What the research says about diet, weight and CMT, why the supplements tested in CMT failed, which ones can hurt nerves, and the rare neuropathies where diet really is the treatment.
-

·
One Patient, One Drug—and a Possible Voucher
A drug made for a single patient is one of the most hopeful ideas in rare disease medicine. Drug companies hope to profit from them, if public funding and exclusive rights defray the costs of developing these drugs. People with rare diseases hope for a cure or better health outcomes. Can both interests align?
-

·
Who Decides What Counts as CMT?
No single body owns the word CMT. Here is where the edge cases sit, who decides, how they decide, and how cmt.blog handles it.
-

·
Name Games: Why CMT Type Names Are a Mess, and How to Find Reliable Information
CMT’s type names grew out of nerve tests and a run of lettered genes. They no longer line up. Here is how the naming got this messy, where it is heading, and which sources to trust.
-

·
Introducing the Open CMT Gene Table
CMT’s gene and subtype names don’t line up, and I haven’t found an open table that sorts them out. So I made one: 70 genes, their old and new names, and how strong the evidence is for each, free to download.
-

·
The Sloth’s Taxonomy: A Review of “Experts in CMT”
Experts in CMT stretches a contested CMT taxonomy wider, brands its uncredentialled author an expert, and cites his employer, the CMTA, without disclosing it as such.
-

·
Differential Diagnosis with Dr. ChatGPT in the House
In a matter of seconds, ChatGPT reviewed and confirmed the findings of three neurologists and a genetic counselor that took me six years to gather. It also suggested a new diagnostic path that was only vaguely hinted at by the human diagnosticians.
-

·
The “First Treatable CMT Disease” is Neither CMT Nor a Disease
CMT-related research may truly do away with CMT disease first by eliminating or updating how naming and classification works in neurological pathology.
-

·
New Gene (PSAT1) Linked to Treatable CMT-like Outcomes
Two children with a CMT-like neuropathy caused by PSAT1 variants improved after taking serine, an early observation from one case report. It raises more questions about how CMT types are defined and diagnosed.
-

·
Disease, Depression, and Family Denial
CMT and other hideable/hidden diseases may often be denied by the people closest to you — a potentially devastating, psychologically defeating, and depressing, gaslit reality that is toxic and abusive.
-

·
Maybe it will work on CMT..?
It seems the new hope for VM202 as a CMT1A treatment is perhaps Helixmith’s latest attempt to find a market for an experimental product that has not panned out as hoped.
-

·
A New Genetic Cause of a Previously Unknown Subtype of CMT2
Published in Nature Genetics last month, the INC group’s findings are a big deal, and there is a really cool story from the University of Miami’s Miller School of Medicine about how the research team came together.
-

·
New Study of Genetic Causes of CMT Needs Participants
The Rare Diseases Network is looking for participants in a new study looking for unknown causes of the most common types of CMT.
-

·
CMT and COVID-19
The Inherited Neuropathy Consortium (INC) is asking for CMTers with a COVID diagnosis to take an anonymous questionnaire.
-

·
Genetic Cause of CMT2 Discovered?
A 2020 study linked JAG1 mutations to axonal CMT2 in two families. Updated in 2026: JAG1-related CMT now has its own OMIM entry, CMT2HH.
-

·
New Genetic Diagnostics for CMT
Current best practice in genetic diagnosis of CMT starts with PMP22 testing. How genetic testing, nerve conduction studies, and EMG lead to a diagnosis.
-

·
The State of Research for Cures (2019)
The US-based CMTA (Charcot Marie Tooth Association) has a 12-year-old program called the Strategy to Accelerate Research (STAR) that is actively pursuing the causes and possible cures for CMT. STAR will cover nearly all CMT Type 1s and 2s, including types with as yet unidentified genetic causes.
